When neurological flow efficiency meets
the learning sweet spot
Educational Immersive Solutions
SWEET FLOW
CURRENT CHALLENGES
The Life Sciences industry faces numerous challenges, this has been pointed out by several actors from Centres of Excellence, to associations and European Governments.
EXPONENTIAL PRODUCTION OF KNOWLEDGE
Technical and Conceptual
KNOWLEDGE SHARING
The difficulty of efficiently managing the sharing of new knowledge through continued education
TALENT SHORTAGE
The shortage of talents subsequently caused by this double bottleneck effect facing the different industrial needs
OUR INNOVATIVE SOLUTION
We propose an innovative solution, putting the Human collective intelligence at the centre.
The heart of our innovation is the immersive learning cycle (ILC). Based on the publications in the psychology of emotions (Paul Ekman), pedagogy (Richard Feynman) and in neurosciences focusing on memorization aspects (Tony Buzan).
PHASE 1
PHASE 2
PHASE 3
IN LESS THAN 1 HOUR
ACQUISITION OF COMPLEX CONCEPTS
Taken together these 3 phases will allow, in less than an hour, the acquisition of complex concepts, via the leverage effect allowed by the spatialization of knowledge and collective intelligence.
USER EXPERIENCE
IMMERSIVE EXPERIENCES
The platform will include areas dedicated to our different target audiences (Pharmaceutical industry, Schools, Academies & Centres of Excellence/Competence) with adapted and relevant contents
The contents will be in the format of scenarios enriched with indicators and the results of collective intelligence discussions
MULTI-DEVICES PLATFORM
People who have followed the training will also have access to immersive experiences, whenever they want to, 24/7
PERSONALIZED COMPONENTS
Once the first users feedback have been collected and our solution has been continuously improved, the ambition is to provide a flexible component and a modelling component. The flexible component would be the possibility of interacting and modifying the scenarios
ESG
Our innovation is intrinsically social-oriented
Ellion has the ambition to develop and to continuously improve a European Metaverse dedicated to the pharmaceutical ecosystem. From a governance aspect, this is a real lever to promote the pharmaceutical ecosystem and have engaging experiences.
By upskilling people in the critical field of pharmaceutical industry, the ultimate customers, the patients, will beneficiate from higher quality medicines and as an ecosystem, we will be able to reduce write-off and failures by better understanding and mastering what we have to do.
PARTNERS
